BridgeMD
New treatment option for Mechanical Ventilation
Official title Neuromuscular Electrical Stimulation in a Patient on Invasive Mechanical Ventilation (MOVCARE)
ClinicalTrials.gov ID: NCT07188350
What this study is testing
- What it's testing
- This clinical study aims to compare the effects of conventional physical therapy alone versus conventional physical therapy combined with neuromuscular electrical stimulation (NMES) in patients admitted to the ICU and undergoing invasive mechanical ventilation. Participants will be randomly assigned to receive either conventional physical therapy or the same therapy plus NMES applied to the lower limbs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients will be eligible if they are 18 years or older, are under invasive mechanical ventilation (IMV), and are expected to require IMV for more...
You likely can't join if
- Body mass index (BMI) greater than or equal to 35 kg/m²;
- Length of ICU stay longer than 7 ICU-free days or more than 3 continuous days of invasive mechanical ventilation (IMV) before enrollment;
- Known intracranial process (e.g., stroke, intracranial hypertension);
- Neuromuscular disease (e.g., Guillain-Barré syndrome, myasthenia gravis) at ICU admission;
- Inability to speak Portuguese or pre-existing cognitive impairment prior to ICU admission;
- Any condition that prevents neuromuscular electrical stimulation (NMES) treatment or assessment of the primary outcome in both legs (e.g., skin...
See the full eligibility criteria
- Patients will be eligible if they are 18 years or older, are under invasive mechanical ventilation (IMV), and are expected to require IMV for more than 48 hours.
- Body mass index (BMI) greater than or equal to 35 kg/m²;
- Length of ICU stay longer than 7 ICU-free days or more than 3 continuous days of invasive mechanical ventilation (IMV) before enrollment;
- Known intracranial process (e.g., stroke, intracranial hypertension);
- Neuromuscular disease (e.g., Guillain-Barré syndrome, myasthenia gravis) at ICU admission;
- Inability to speak Portuguese or pre-existing cognitive impairment prior to ICU admission;
- Any condition that prevents neuromuscular electrical stimulation (NMES) treatment or assessment of the primary outcome in both legs (e.g., skin lesions, fractures, or amputation);
- inability to transfer from bed to chair with or without assistance prior to hospital admission;
- Cardiac arrest as the cause of ICU admission or cardiac arrest before screening;
- Deep vein thrombosis (DVT) or pulmonary embolism (PE) treated for less than 48 hours;
- Pregnant patients;
- Known or suspected malignancy in the legs;
- Any care limitation including a do-not-resuscitate order.
The study team makes the final eligibility decision.
Where it's taking place
- Porto Alegre, Rio Grande do Sul, Brazil
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Porto Alegre, Rio Grande do Sul, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.